The global government expenditures on R&D in health vary significantly across countries. In 2023, Spain led with $5.31 billion USD PPP, followed by the UK and Germany, illustrating a strong focus among European nations. Notably, countries like Greece and Belgium showed significant year-on-year growth of over 5% and 10%, respectively, indicating an increasing investment trend. Conversely, Japan and Israel saw a decline in their investments, with Japan experiencing a near 10% decrease. Finland and Iceland face negative trends, with Iceland’s spending plummeting by over 40% compared to last year.
Future trends in government health R&D expenditures are expected to be influenced by factors including technological advancements, healthcare crises, and economic conditions. Countries may increase or maintain high levels of investment to cope with emerging healthcare challenges and innovation demands. Watch for emerging economies potentially increasing their share in the global R&D stage, alongside ongoing fluctuations in traditionally dominant countries amid socio-economic shifts.
Top countries in Government Expenditures on R&D Health by Country
| # | 10 Countries | Million US Dollars PPP | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Spain | 5,310 | 2023 | +1.44% | +2.19% | View data |
| 2 | 2 United Kingdom | 4,920 | 2023 | +1.75% | +2.5% | View data |
| 3 | 3 Germany | 4,220 | 2023 | +2.53% | +2.77% | View data |
| 4 | 4 Netherlands | 4,060 | 2023 | +2.57% | +2.68% | View data |
| 5 | 5 Australia | 3,230 | 2023 | +3.02% | +2.23% | View data |
| 6 | 6 France | 3,030 | 2023 | +0.44% | +0.89% | View data |
| 7 | 7 Austria | 2,610 | 2023 | +2.17% | +2.81% | View data |
| 8 | 8 Italy | 2,450 | 2023 | +0.14% | +0.61% | View data |
| 9 | 9 Norway | 1,630 | 2023 | +2.16% | +2.13% | View data |
| 10 | 10 Poland | 1,280 | 2023 | +2.95% | +1.98% | View data |
